- Home
- GCTK vs MTNB Comparison
GCTK vs MTNB Comparison
Compare GCTK & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- MTNB
- Stock Information
- Founded
- GCTK 2001
- MTNB 2013
- Country
- GCTK United States
- MTNB United States
- Employees
- GCTK N/A
- MTNB N/A
- Industry
- GCTK Medical/Dental Instruments
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- GCTK Health Care
- MTNB Health Care
- Exchange
- GCTK Nasdaq
- MTNB Nasdaq
- Market Cap
- GCTK 3.7M
- MTNB 3.6M
- IPO Year
- GCTK N/A
- MTNB N/A
- Fundamental
- Price
- GCTK $5.60
- MTNB $1.00
- Analyst Decision
- GCTK
- MTNB Hold
- Analyst Count
- GCTK 0
- MTNB 1
- Target Price
- GCTK N/A
- MTNB N/A
- AVG Volume (30 Days)
- GCTK 1.6M
- MTNB 306.7K
- Earning Date
- GCTK 08-12-2025
- MTNB 08-13-2025
- Dividend Yield
- GCTK N/A
- MTNB N/A
- EPS Growth
- GCTK N/A
- MTNB N/A
- EPS
- GCTK N/A
- MTNB N/A
- Revenue
- GCTK N/A
- MTNB N/A
- Revenue This Year
- GCTK N/A
- MTNB N/A
- Revenue Next Year
- GCTK N/A
- MTNB N/A
- P/E Ratio
- GCTK N/A
- MTNB N/A
- Revenue Growth
- GCTK N/A
- MTNB N/A
- 52 Week Low
- GCTK $5.16
- MTNB $0.47
- 52 Week High
- GCTK $3,756.00
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- GCTK 40.61
- MTNB 59.85
- Support Level
- GCTK $5.61
- MTNB $0.88
- Resistance Level
- GCTK $7.38
- MTNB $1.05
- Average True Range (ATR)
- GCTK 1.25
- MTNB 0.07
- MACD
- GCTK 0.04
- MTNB 0.00
- Stochastic Oscillator
- GCTK 4.40
- MTNB 72.68
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.